Jorge da Silva
Founder at MOONLAKE IMMUNOTHERAPEUTICS
Net worth: 129 M $ as of 2024-05-30
Profile
Jorge Santos da Silva is the founder and currently serves as the Chief Executive Officer & Director at MoonLake Immunotherapeutics.
He founded MoonLake Immunotherapeutics in 2022.
He also founded Moonlake Immunotherapeutics AG in 2021 and served as the Chief Executive Officer.
Dr. da Silva's current job is as a Professor at the University of Minho.
Previously, he worked at McKinsey & Co., Inc. as a Senior Partner from 2007 to 2021.
Dr. da Silva obtained his undergraduate degree from the University of Glasgow and his doctorate degree from the University of Turin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-14 | 2,982,814 ( 4.74% ) | 121 M $ | 2024-05-30 | |
| 2024-03-14 | 196,316 ( 2.19% ) | 8 M $ | 2024-05-30 |
Jorge da Silva active positions
| Companies | Position | Start |
|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Founder | 2022-04-04 |
| University of Minho | Corporate Officer/Principal | - |
Former positions of Jorge da Silva
| Companies | Position | End |
|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 2021-05-31 |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Chief Executive Officer | - |
Training of Jorge da Silva
| University of Turin | Doctorate Degree |
| University of Glasgow | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
| Private companies | 2 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
- Stock Market
- Insiders
- Jorge da Silva
